Access the full text.
Sign up today, get DeepDyve free for 14 days.
Q. Walker, R. Mailman (1996)
Triadimefon and triadimenol: effects on monoamine uptake and release.Toxicology and applied pharmacology, 139 2
G. Corsini, S. Pintus, C. Chiueh, J. Weiss, I. Kopin (1985)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.European journal of pharmacology, 119 1-2
C. Tanner (1989)
The role of environmental toxins in the etiology of Parkinson's diseaseTrends in Neurosciences, 12
Smith Ll (1988)
The toxicity of paraquat.Adverse drug reactions and acute poisoning reviews, 7 1
S. Snyder, R. D'Amato (1985)
Neurology: Predicting Parkinson's diseaseNature, 317
Wan-lin Yang, A. Sun (2004)
Paraquat-Induced Free Radical Reaction in Mouse Brain MicrosomesNeurochemical Research, 23
Reinaldo Takahashi, R. Rogerio, M. Zanin (1989)
Maneb enhances MPTP neurotoxicity in mice.Research communications in chemical pathology and pharmacology, 66 1
A. Vaccari, P. Saba, S. Ruiu, M. Collu, P. Devoto (1996)
Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.Toxicology and applied pharmacology, 139 1
B. Chan, V. Lazzaro, J. Seale, G. Duggin (1996)
Transport of paraquat in a renal epithelial cell line LLC-PK1.The Journal of pharmacology and experimental therapeutics, 279 2
K. Chiba, A. Trevor, N. Castagnoli (1985)
Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.Biochemical and biophysical research communications, 128 3
M. Rose, E. Lock, L. Smith, I. Wyatt (1976)
Paraquat accumulation: tissue and species specificity.Biochemical pharmacology, 25 4
T. Perry, V. Yong, R. Wall, K. Jones (1986)
Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouseNeuroscience Letters, 69
C. Tanner, R. Ottman, S. Goldman, J. Ellenberg, P. Chan, R. Mayeux, J. Langston (1999)
Parkinson disease in twins: an etiologic study.JAMA, 281 4
S. Doolen, N. Zahniser (2001)
Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.The Journal of pharmacology and experimental therapeutics, 296 3
Eve Taylor (2002)
The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS DisordersClinical Pharmacokinetics, 41
D. Woolley, D. Gietzen, S. Gee, J. Magdalou, B. Hammock (1989)
Does paraquat (PQ) mimic MPP+ toxicity?Proceedings of the Western Pharmacology Society, 32
L. Adams-Carr, BA Mbbs, Alastair Noyce (1985)
Predicting Parkinson's disease.Nature, 317 6034
Lei Zhang, M. Dresser, A. Gray, S. Yost, S. Terashita, K. Giacomini (1997)
Cloning and functional expression of a human liver organic cation transporter.Molecular pharmacology, 51 6
C. Altar, R. Heikkila, L. Manzino, M. Marien (1986)
1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation.European journal of pharmacology, 131 2-3
H. Witschi, S. Kacew, K. Hirai, M. Côté (1977)
In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung.Chemico-biological interactions, 19 2
I. Irwin, E. Wu, L. Delanney, A. Trevor, J. Langston (1987)
The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.European journal of pharmacology, 141 2
S. Bachurin, Shevtzova Ep, N. Lermontova, T. Serkova, R. Ramsay (1996)
The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain.Neurotoxicology, 17 3-4
H. Schoemaker, V. Nickolson (1983)
Dopamine Uptake by Rat Striatal Synaptosomes: A Compartmental AnalysisJournal of Neurochemistry, 41
R. Fuente-Fernández, D. Calne (2002)
Evidence for environmental causation of Parkinson's disease.Parkinsonism & related disorders, 8 4
M. Thiruchelvam, E. Richfield, R. Baggs, A. Tank, D. Cory-Slechta (2000)
The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's DiseaseThe Journal of Neuroscience, 20
(2001)
Dithiocarbamate pesticides , ethlylenethiourea and propylthiourea : a general introduction
D. McGrew, I. Irwin, J. Langston (2000)
Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.Neurotoxicology, 21 3
Donald Jack, I. Paulsen, M. Saier (2000)
The amino acid/polyamine/organocation (APC) superfamily of transporters specific for amino acids, polyamines and organocations.Microbiology, 146 ( Pt 8)
L. Smith, M. Rose, I. Wyatt (1978)
The pathology and biochemistry of paraquat.Ciba Foundation symposium, 65
G. Meco, V. Bonifati, N. Vanacore, E. Fabrizio (1994)
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).Scandinavian journal of work, environment & health, 20 4
L. Smith, I. Wyatt (1981)
The accumulation of putrescine into slices of rat lung and brain and its relationship to the accumulation of paraquat.Biochemical pharmacology, 30 10
C. Aprea, C. Colosio, Teresa Mammone, C. Minoia, M. Maroni (2002)
Biological monitoring of pesticide exposure: a review of analytical methods.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 769 2
K. Semchuk, E. Love, Robert Lee (1992)
Parkinson's disease and exposure to agricultural work and pesticide chemicalsNeurology, 42
M. Thiruchelvam, B. Brockel, E. Richfield, R. Baggs, D. Cory-Slechta (2000)
Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?Brain Research, 873
A. Zuddas, G. Corsini, S. Schinelli, J. Johannessen, U. Porzio, I. Kopin (1989)
MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigraBrain Research, 501
William Koller (1986)
Paraquat and Parkinson's diseaseNeurology, 36
E. Richfield (1993)
Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.Molecular pharmacology, 43 1
C. Bliss (1939)
THE TOXICITY OF POISONS APPLIED JOINTLY1Annals of Applied Biology, 26
A. Busch, U. Karbach, D. Miska, V. Gorboulev, A. Akhoundova, C. Volk, P. Arndt, J. Ulzheimer, M. Sonders, Carmen Baumann, S. Waldegger, Florian Lang, H. Koepsell (1998)
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.Molecular pharmacology, 54 2
R. Harman, G. Shaw (1981)
High‐Affinity Uptake of Spermine by Slices of Rat Cerebral CortexJournal of Neurochemistry, 36
S. Kitayama, Chieko Mitsuhata, STEPHEN Davis, Jia-Bei Wang, Tomoyuki Sato, K. Morita, George Uhl, T. Dohi (1998)
MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.Biochimica et biophysica acta, 1404 3
(2000)
Polyamine uptake in cultured astrocytes: characterization and modulation by protein kinases
C. Hertzman, M. Wiens, D. Bowering, Barry Snow, D. Calne (1990)
Parkinson's disease: a case-control study of occupational and environmental risk factors.American journal of industrial medicine, 17 3
D. Miller, J. Reinhard, A. Daniels, J. O'Callaghan (1991)
Diethyldithiocarbamate Potentiates the Neurotoxicity of In Vivo l‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine and of In Vitro 1‐Methyl‐4‐PhenylpyridiniumJournal of Neurochemistry, 57
S. Ambudkar, S. Dey, C. Hrycyna, M. Ramachandra, I. Pastan, M. Gottesman (1999)
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.Annual review of pharmacology and toxicology, 39
G. Gilad, V. Gilad (1991)
Polyamine uptake, binding and release in rat brain.European journal of pharmacology, 193 1
(2001)
Paraquat induced cell loss in the mouse substantia nigra
Y. Lau, K. Trobough, James Crampton, John Wilson (1990)
Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.General pharmacology, 21 2
J. Javitch, R. D'Amato, S. Strittmatter, S. Snyder (1985)
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proceedings of the National Academy of Sciences of the United States of America, 82 7
C. Groves, M. Morales, A. Gandolfi, W. Dantzler, S. Wright (1995)
Peritubular paraquat transport in isolated renal proximal tubules.The Journal of pharmacology and experimental therapeutics, 275 2
K. Semchuk, E. Love, Robert Lee (1991)
Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control StudyCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 18
L. Smith, I. Wyatt, G. Cohen (1982)
The accumulation of diamines and polyamines into rat lung slices.Biochemical pharmacology, 31 19
F. Cassee, J. Groten, P. Bladeren, V. Feron (1998)
Toxicological evaluation and risk assessment of chemical mixtures.Critical reviews in toxicology, 28 1
E. Leslie, R. Deeley, S. Cole (2001)
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.Toxicology, 167 1
J. Poirier, Sandra Kogan, S. Gauthier (1991)
Environment, Genetics and Idiopathic Parkinson's DiseaseCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 18
J. Johannessen, C. Chiueh, R. Burns, S. Markey (1985)
Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.Life sciences, 36 3
P. Diliberto, R. Jeffs, L. Cubeddu (1989)
Effects of low extracellular chloride on dopamine release and the dopamine transporter.The Journal of pharmacology and experimental therapeutics, 248 2
C. Wesseling, Berna Joode, C. Ruepert, Catalina León, P. Monge, Hernán Hermosillo, Limo Partanen (2001)
Paraquat in Developing CountriesInternational Journal of Occupational and Environmental Health, 7
P. Keeling, Lewis Smith (1982)
Relevance of NADPH depletion and mixed disulphide formation in rat lung to the mechanism of cell damage following paraquat administration.Biochemical pharmacology, 31 20
H. Schoemaker, V. Nickolson (1982)
Interaction between dopamine influx and efflux in rat striatal synaptosomes.Life sciences, 31 22
H. Liou, M. Tsai, Chien-Jen Chen, J. Jeng, Yu-Chia Chang, S. Chen, Rong-Chi Chen (1997)
Environmental risk factors and Parkinson's diseaseNeurology, 48
(1976)
INTERNATIONAL SOCIETY FOR NEUROCHEMISTRYJournal of Neurochemistry, 26
R. Drew, Z. Siddik, T. Gram (1979)
Uptake and efflux of 14C-paraquat by rat lung slices: the effect of imipramine and other drugs.Toxicology and applied pharmacology, 49 3
A. Zuddas, G. Corsini, S. Schinelli, J. Barker, I. Kopin, U. Porzio (1989)
Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatumBrain Research, 501
D. Yurek, A. Deutch, R. Roth, J. Sladek (1989)
Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in miceBrain Research, 497
T. Endo, S. Hara, S. Kano, F. Kuriwa (1988)
Effects of a paraquat-containing herbicide, gramoxon®, on the central monoamines and acetylcholine in miceResearch communications in psychology, psychiatry and behavior, 13
György Lonart, M. Zigmond (1991)
High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport.The Journal of pharmacology and experimental therapeutics, 256 3
M. Raiteri, F. Cerrito, Cervoni Am, G. Levi (1979)
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.The Journal of pharmacology and experimental therapeutics, 208 2
M. Thiruchelvam, A. McCormack, E. Richfield, R. Baggs, A. Tank, D. Monte, D. Cory-Slechta (2003)
Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotypeEuropean Journal of Neuroscience, 18
A. Brooks, Christopher Chadwick, H. Gelbard, D. Cory-Slechta, H. Federoff (1999)
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron lossBrain Research, 823
Xiang Wu, R. Kekuda, Wei Huang, Y. Fei, F. Leibach, Jinwen Chen, S. Conway, V. Ganapathy (1998)
Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain*The Journal of Biological Chemistry, 273
Aishah Adam, Lewis Smith, Gerald Cohen (1990)
An assessment of the role of redox cycling in mediating the toxicity of paraquat and nitrofurantoin.Environmental Health Perspectives, 85
A. McCormack, M. Thiruchelvam, A. Manning-Boğ, C. Thiffault, J. Langston, D. Cory-Slechta, D. Monte (2002)
Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide ParaquatNeurobiology of Disease, 10
Tessa Walters, I. Irwin, K. Delfani, J. Langston, A. Janson (1999)
Diethyldithiocarbamate Causes Nigral Cell Loss and Dopamine Depletion with Nontoxic Doses of MPTPExperimental Neurology, 156
I. Holland, Mark Blight (1999)
ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans.Journal of molecular biology, 293 2
P. Widdowson, MJ Farnworth, R. Upton, M. Simpson (1996)
No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to ratsHuman & Experimental Toxicology, 15
M. Thiruchelvam, E. Richfield, Becky Goodman, R. Baggs, D. Cory-Slechta (2002)
Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.Neurotoxicology, 23 4-5
Exposure to pesticides may be a risk factor for Parkinson's disease based on epidemiologic data in humans, animal models and in vitro studies. Different dithiocarbamate pesticides potentiate the toxicity of both 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine and paraquat in mouse models of Parkinsonism by an unknown mechanism. This study examined the effects of commercially used dithiocarbamates on [3H]dopamine transport in striatal synaptosomal vesicles and on the concentration of [14C]paraquat in vivo in mice. Different ethylenebis‐dithiocarbamates and diethyl‐dithiocarbamate increased dopamine accumulation in synaptosomes, whereas dimethyl‐dithiocarbamate and methyl‐dithiocarbamate did not. Increased dopamine accumulation in synaptosomes was dose dependent and was related to the carbon backbone of these molecules. The dithiocarbamates that increased accumulation of dopamine did not alter the influx of dopamine, but rather delayed the efflux out of synaptosomes. These same dithiocarbamates also increased the tissue content of [14C]paraquat in vivo by a mechanism that appeared to be distinct from the dopamine transporter. There was a consistent relationship between the dithiocarbamates that increased synaptosomal accumulation of dopamine and tissue content of paraquat, with those previously demonstrated to enhance paraquat toxicity in vivo. These results suggest that selective dithiocarbamates may alter the kinetics of different endogenous and exogenous compounds to enhance their neurotoxicity.
Journal of Neurochemistry – Wiley
Published: Jan 1, 2003
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.